TNRC9 downregulates BRCA1 expression and promotes breast cancer aggressiveness

Cancer Research

Volumn 73, Issue 9, 2013, Pages 2840-2849

  Shan, Jingxuan ^a   DSouza, Shoba P ^a   Bakhru, Sasha ^e   Al Azwani, Eman K ^b   Ascierto, Maria L ^f   Sastry, Konduru S ^a   Bedri, Shahinaz ^c   Kizhakayil, Dhanya ^a   Aigha, Idil I ^a   Malek, Joel ^b   Al Bozom, Issam ^d   Gehani, Salah ^d   Furtado, Stacia ^e   Mathiowitz, Edith ^e   Wang, Ena ^f   Marincola, Francesco M ^f   Chouchane, Lotfi ^a,g  

^a Laboratory of Genetic Medicine and Immunology   (United States)

^b Genomics Core ^*  (United States)

^c QATAR FOUNDATION   (Qatar)

^d HAMAD MEDICAL CORPORATION   (Qatar)

^e BROWN UNIVERSITY   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; NUCLEAR PROTEIN; TRINUCLEOTIDE REPEAT CONTAINING 9 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER SUSCEPTIBILITY; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COMPUTER MODEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DISEASE MODEL; DOWN REGULATION; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; METASTASIS FREE SURVIVAL; METHYLATION; MOUSE; NONHUMAN; ONCOGENE; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; TNRC9 GENE; TUMOR GROWTH;

ADULT; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BRCA1; HEK293 CELLS; HUMANS; MICE; MIDDLE AGED; MODELS, GENETIC; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHENOTYPE; RECEPTORS, PROGESTERONE;

EID: 84877786902     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-4313     Document Type: Article

References (36)

1. IARC 2010, WHO, Globocan 2008. Available from: http://globocan. iarc.fr/factsheets/cancers/breast.asp.
2. Razzak AR, Lin NU, Winer EP. Heterogeneity of breast cancer and implications of adjuvant chemotherapy. Breast Cancer 2008;15:31-4.
3. Leber MF, Efferth T. Molecular principles of cancer invasion and metastasis. Int J Oncol 2009;34:881-95.
4. Anderson WF, Matsuno R. Breast cancterogeneity: a mixture of at least two main types? J Natl Cancer Inst 2006;98:948-51.
5. Ponder BAJ. Cancer genetics. Nature 2001;411:336-41.
6. Antoniou AC, Pharoah PD,McMullan G, Day NE, Ponder BA, Easton D. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 2001;21:1-18.
7. Di LJ, Fernandez AG, Siervi A, De Longo DL, Gardner K. Transcriptional regulation of BRCA1 expression by a metabolic switch. Nat Struct Mol Biol 2010;17:1406-13.
8. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007;447:1087-93.
9. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, et al.Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2007;39:865-9.
10. Ruiz-Narvaez EA, Rosenberg L, Cozier YC, Cupples LA, Adams- Campbell LL, Palmer Jr. Polymorphisms in the TOX3/LOC643714 locus and risk of breast cancer in African-American women. Cancer Epidemiol Biomarkers Prev 2010;19:1320-7.
11. Chen MB, Wu XY, Shen W, Wei MX, Li C, Cai B, et al. Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk: evidence from 62,005 subjects. Breast Cancer Res Treat 2011;126:177-83.
12. Yuan SH, Qiu Z, Ghosh A. TOX3 regulates calcium-dependent transcription in neurons. Proc Natl Acad Sci U S A 2009;106:2909-14.
13. Dittmer S, Kovacs Z, Yuan SH, Siszler G, Kögl M, Summer H, et al. TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex. J Cell Sci 2011;124:252-60.
14. Turner NC, Reis-Filho JS, Russell AM, Springall RJ, Ryder K, Steele D, et al. BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene 2007;26:2126-32.
15. Wilson CA, Ramos L, Villaseñor MR, Anders KH, Press MF, Clarke K, et al. Localization of human BRCA1 and its loss in high-grade, noninherited breast carcinomas. Nat Genet 1999;21:236-40.
16. Hockings JK, Degner SC, Morgan SS, Kemp MQ, Romagnolo DF. Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene. Breast Cancer Res 2008;10:R29.
17. Shlien A, Malkin D. Copy number variations and cancer. Genome Med 2009;1:62.
18. Kuiper RP. Germline copy number variation and cancer risk. Curr Opin Genet Dev 2010;20:282-9.
19. Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, et al. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci U S A 1998;95:14821-6.
20. Sabatier R, Finetti P, Cervera N, Lambaudie E, Esterni B, Mamessier E, et al. A gene expression signature identifies two prognostic subgroups of basal breast cancer. Breast Cancer Res Treat 2011;126:407-20.
21. Simon R,Lam A, Li MC, Ngan M, Menenzes S, Zhao Y. Analysis of gene expression data using BRB-array tools. Cancer Inform 2007;3:11-7.
22. Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS. A census of amplified and overexpressed human cancer genes. Nat Rev Cancer 2010;10:59-64.
23. Atlas E, Stramwasser M, Mueller CR. A CREB site in the BRCA1 proximal promoter acts as a constitutive transcriptional element. Oncogene 2001;20:7110-4.
24. Callens N, Baert JL, Monte D, Sunesen M, Van Lint C, de Launoit Y. Transcriptional regulation of the murine brca2 gene by CREB/ATF Transcription factors. Biochem Biophys Res Commun 2003;312: 702-7.
25. Romagnolo D, Annab LA, Thompson TE, Risinger JI, Terry LA, Barrett JC, et al. Estrogen upregulation of BRCA1 expression with no effect on localization. Mol Carcinogen 1998;22:102-9.
26. Gudas JM, Nguyen H, Li T, Cowan KH. Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res 1995;55: 4561-5.
27. Wei M, Grushko TA, Dignam J, Hagos F, Nanda R, Sveen L, et al. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. Cancer Res 2005;65:10692-9.
28. Rice JC, Massey-Brown KS, Futscher BW. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene 1998;17:1807-12.
29. Rice JC, Ozcelik H, Maxeiner P, Andrulis I, Futscher BW. Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis 2000;21: 1761-5.
30. Jin W, Chen L, Chen Y, Xu SG, Di GH, Yin WJ, et al. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer. Breast Cancer Res Treat 2010;123:359-73.
31. Ravasi T, Suzuki H, Cannistraci CV, Katayama S, Bajic VB, Tan K, et al. An atlas of combinatorial transcriptional regulation in mouse and man. Cell 2010;140:744-52.
32. Chalabi N, Bernard-Gallon DJ, Bignon YJ, Kwiatkowski F, Agier M, Vidal V, et al. Comparative clinical and transcriptomal profiles of breast cancer between French and South Mediterranean patients showminor but significative biological differences. Cancer Genomics Proteomics 2008;5:253-6.
33. Mahfoudh W, Bouaouina N, Ahmed SB, Gabbouj S, Shan J, Mathew R, et al. Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population. Mol Biol Rep 2012;39: 1037-46.
34. Smid M, Wang Y, Klijn JG, Sieuwerts AM, Zhang Y, Atkins D, et al. Genes associated with breast cancer metastatic to Bone. J Clin Oncol 2006;24:2261-7.
35. Kaplan EL, Meir PO.Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-61.
36. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977;35:1-39.